Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer
Public ClinicalTrials.gov record NCT02069093. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Study identification
- NCT ID
- NCT02069093
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 92 participants
Conditions and interventions
Conditions
Interventions
- Dexamethasone based mouthwash Drug
- Everolimus Drug
- Exemestane Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2014
- Primary completion
- Feb 29, 2016
- Completion
- Feb 29, 2016
- Last update posted
- Feb 12, 2017
2014 – 2016
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Highlands Oncology Group Highlands Oncology Group (22) | Fayetteville | Arkansas | 72703 | — |
| Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C | Anaheim | California | 92807 | — |
| Los Angeles Hematology/Oncology Medical Group | Los Angeles | California | 90017 | — |
| University of California at Los Angeles UCLA and TRIO Network | Los Angeles | California | 90095-6956 | — |
| University of California Irvine UC Irvine Medical Center | Orange | California | 92868 | — |
| University of California San Francisco UCSF Medical Center | San Francisco | California | 94101 | — |
| California Pacific Medical Center SC | San Francisco | California | 94115 | — |
| University of Connecticut Health Center | Farmington | Connecticut | 06030-3940 | — |
| Southeastern Regional Medical Center | Newnan | Georgia | 30265 | — |
| OnCare Hawaii | ‘Aiea | Hawaii | 96701 | — |
| North Shore University Health System NorthShore University | Evanston | Illinois | 60201 | — |
| Oncology Specialists, SC Onc Specialists | Park Ridge | Illinois | 60068-0736 | — |
| University of Maryland School of Medicine University of Maryland | Baltimore | Maryland | 21201-1559 | — |
| Kaiser Permanente - Mid Atlantic Permanete Research Institut Kaiser Permanente Mid-Atlantic | Rockville | Maryland | 20850 | — |
| Karmanos Cancer Institute Karmanos Cancer Institute (2) | Detroit | Michigan | 48201 | — |
| Saint Luke's Hospital/Marion Bloch Neuroscience Institute Cancer Institute | Kansas City | Missouri | 64111 | — |
| Regional Cancer Care Associates Cancer and Hematologic Disease | Cherry Hill | New Jersey | 08003 | — |
| Hematology Oncology Associates of Northern New Jersey PA DeptofHem-OncofNorthern NJ (2) | Morristown | New Jersey | 07962 | — |
| M. Francisco Gonzalez, MD.PA Hematology Oncology Center | Columbia | South Carolina | 29203 | — |
| Oncology Consultants Oncology Consultants, P.A. | Houston | Texas | 77024 | — |
| University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(2) | Houston | Texas | 77030-4009 | — |
| Delta Oncology Associates Delta Hematology/Oncology | Portsmouth | Virginia | 23704 | — |
| Northwest Medical Specialties Northwest Medical - Puyallup | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02069093, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 12, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02069093 live on ClinicalTrials.gov.